Research Article

Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation

Table 1

Demographics, comorbidities, payer status, and hospital data for patients hospitalized for atrial fibrillation.

No cardioversion Cardioversion value

Demographics
Age (years)<0.0001
 ≤40262580 (9.6%)1275 (1%)
 40–64 752172 (27.6%)42332 (34.7%)
 65–74605721 (22.2%)30118 (24.7%)
 ≥751108150 (40.6%)36644 (30.1%)
Sex <0.001
 Men1282442 (46.9%)70983 (58.4%)
 Women1453591 (53.1%)50611 (41.6%)
Race<0.0001
 White2223231 (81.5%)105241 (86.4%)
 Black220210 (8.1%)7225 (5.9%)
 Others285236 (10.5%)9374 (7.7%)
Comorbidities
Hypertension1043744 (38.3%)49886 (40.9%)<0.0001
Diabetes571796 (20.9%)21596 (17.8%)<0.001
Congestive heart failure403164 (14.7%)16330 (13.4%)0.0012
CHADS2 score<0.0001
 034529414603
 179907230766
 >1158431276471
Payer status<0.0001
Private737885 (27.1%)45040 (37%)
Medicare1662845 (61%)64805 (53.2%)
Medicaid173315 (6.4%)6175 (5.1%)
Others 151140 (5.5%)5660 (4.6%)
Hospital type<0.001
Teaching center1064453 (39.2%)57191 (47.1%)
Nonteaching center1651500 (60.8%)64177 (52.9%)